| [1] |
Hara T. 11C-Choline and 2-deoxy-2-[18F]fluoro-d-glucose in tumor imaging with positron emission tomography[J].Mol Imag Biol, 2002, 4(4):267-273.
|
| [2] |
Shinoura N, Nishijima M, Hara T, et al. Brain tumors:detection with C-11 choline PET[J]. Radiology, 1997, 202(2):497-503.
|
| [3] |
DeGrado TR, Baldwin SW, Wang S, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers[J]. J Nucl Med, 2001, 42(12):1805-1814.
|
| [4] |
Hara T, Inagaki K, Kosaka N, et al. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET[J]. J Nucl Med,2000, 41(9):1507-1513.
|
| [5] |
Hara T, Yuasa M. Automated synthesis of [11C]choline, a positron-emiaing tracer for tumor imaging[J]. Appl Radiat Isot, 1999, 50(3):531-533.
|
| [6] |
Ohtani T, Kurihara H, Ishiuchi S, et al. Brain tumor imaging with carbon-11 choline:comparison with FDG PET and gadolinium-enhanced MR imaging[J]. Eur J Nucl Med, 2001,28(11):1664-1670.
|
| [7] |
Pieterman RM, Que TH, Elsinga PH, et al. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer[J]. J Nucl Med,2002, 43(2):167-172.
|
| [8] |
Jager PL, Que TH, Vaalburg W, et al. Carbon-11 choline or FDG-PET for staging of oesophageal cancer?[J]. Eur J Nucl Med, 2001, 28(12):1845-1849.
|
| [9] |
Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline[J]. J Nucl Med, 1998, 39(6):990-995.
|
| [10] |
Iwata R, Pascali C, Bogni A, et al.[18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent:preparation and application to the on-column preparation of [18F]fluorocholine[J]. Appl Radiat Isos, 2002, 57(3):347-352.
|
| [11] |
DeGrado TR, Coleman RE, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography:initial findings in prostate cancer[J]. Cancer Res, 2001, 61(1):110-117.
|
| [12] |
Price DT, Coleman RE, Liao RP, et al. Comparison of [18F]fluorocholine and[18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer[J]. J Urol, 2002, 168(1):273-280.
|